Matches in Wikidata for { <http://www.wikidata.org/entity/Q91981317> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q91981317 description "article scientifique publié en 2020" @default.
- Q91981317 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91981317 description "scientific article published on 16 April 2020" @default.
- Q91981317 description "wetenschappelijk artikel" @default.
- Q91981317 description "наукова стаття, опублікована 16 квітня 2020" @default.
- Q91981317 name "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 name "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 type Item @default.
- Q91981317 label "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 label "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 prefLabel "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 prefLabel "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 P1433 Q91981317-B9011B12-20FD-4FF1-A8BC-BA9EE526E643 @default.
- Q91981317 P1476 Q91981317-A19EF415-8F01-4E6B-BE00-DF30FCE1FF88 @default.
- Q91981317 P2093 Q91981317-13D165D0-96E7-4301-925D-54D90CD157BE @default.
- Q91981317 P2093 Q91981317-2A594C89-8D55-4621-B049-7568FF919B40 @default.
- Q91981317 P2093 Q91981317-3462FC51-A13E-4D03-B86C-3ACDD04F8F06 @default.
- Q91981317 P2093 Q91981317-34FC7B9A-2502-4C10-986D-C53557C5B151 @default.
- Q91981317 P2093 Q91981317-41920EA9-986E-4433-840F-D0B46BF6D86E @default.
- Q91981317 P2093 Q91981317-8BAB3E77-A432-47D4-B3EA-370D9D4F8931 @default.
- Q91981317 P2093 Q91981317-974C2BA5-9ED3-456B-99B9-2C317F8E8BC8 @default.
- Q91981317 P2093 Q91981317-9A017C78-1B8A-4C2A-BB0B-928461F64222 @default.
- Q91981317 P2093 Q91981317-A0E550DB-8B83-4548-A31B-FEBE6637E661 @default.
- Q91981317 P2093 Q91981317-A95E72BE-77A0-4253-92F9-26FC0BD35C5C @default.
- Q91981317 P2093 Q91981317-DA960CEC-4E02-4BE8-A3FA-05F2A643EC74 @default.
- Q91981317 P2093 Q91981317-F3AB6E5B-AB5D-444A-A2AD-C74B7F276801 @default.
- Q91981317 P2093 Q91981317-F9996372-8151-4614-ABA1-F723C4A313F9 @default.
- Q91981317 P304 Q91981317-FC36F6CB-3E6B-4D57-A166-8B3AD72E9934 @default.
- Q91981317 P31 Q91981317-EE3AAD91-8AC6-4669-8049-D1241D929CEA @default.
- Q91981317 P356 Q91981317-B63749C9-EFD7-465F-9227-883F4BAFA61A @default.
- Q91981317 P50 Q91981317-2B9AD719-01BF-4B25-9B16-1610E1330DD4 @default.
- Q91981317 P577 Q91981317-44D14583-CE3C-460B-AF75-A35F015E2ACC @default.
- Q91981317 P698 Q91981317-794BD8F4-F729-499D-9A8E-B30819419287 @default.
- Q91981317 P921 Q91981317-20F076E6-2FDB-4021-A859-2B70D9DA6EC8 @default.
- Q91981317 P921 Q91981317-CA315B4F-2B02-459D-BB30-9B0A38620972 @default.
- Q91981317 P921 Q91981317-E23ED34C-6575-43B6-99D0-C6466DC13BCD @default.
- Q91981317 P921 Q91981317-FB761247-399A-4C61-AEA0-8C61B26A7220 @default.
- Q91981317 P356 0284186X.2020.1750696 @default.
- Q91981317 P698 32297532 @default.
- Q91981317 P1433 Q326164 @default.
- Q91981317 P1476 "Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors" @default.
- Q91981317 P2093 "Annelies Verbiest" @default.
- Q91981317 P2093 "Benoit Beuselinck" @default.
- Q91981317 P2093 "Eduard Roussel" @default.
- Q91981317 P2093 "Evelyne Lerut" @default.
- Q91981317 P2093 "Frederik De Keyzer" @default.
- Q91981317 P2093 "Geert Vanderschueren" @default.
- Q91981317 P2093 "Jurgen Bielen" @default.
- Q91981317 P2093 "Liesbeth De Wever" @default.
- Q91981317 P2093 "Maarten Albersen" @default.
- Q91981317 P2093 "Marcella Baldewijns" @default.
- Q91981317 P2093 "Nathalie Noppe" @default.
- Q91981317 P2093 "Steven Pans" @default.
- Q91981317 P2093 "Vincent Vandecaveye" @default.
- Q91981317 P304 "1-7" @default.
- Q91981317 P31 Q13442814 @default.
- Q91981317 P356 "10.1080/0284186X.2020.1750696" @default.
- Q91981317 P50 Q60683824 @default.
- Q91981317 P577 "2020-04-16T00:00:00Z" @default.
- Q91981317 P698 "32297532" @default.
- Q91981317 P921 Q1164529 @default.
- Q91981317 P921 Q19000948 @default.
- Q91981317 P921 Q574834 @default.
- Q91981317 P921 Q899360 @default.